Skip to main content
. 2016 Jul 5;12(3):1556–1562. doi: 10.3892/etm.2016.3506

Figure 3.

Figure 3.

Changes to myocardial cell surface area observed following transfection with miR-155 analogue or inhibitor and/or treatment with AngII. (A) Micrographs of the cells (magnification, ×200); (B) Cell surface area among the groups. *P<0.05, vs. the control group; #P<0.05, vs. the AngII group. AngII, angiotensin II.